Shavit Capital

• Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate UpdateJune 5, 2023
• Galooli ramps energy management business in U.S.June 5, 2023
• KAHR Reports Dose Escalation Results from Phase I Trial of DSP107 in Combination with anti-PD-L1 in Patients with Advanced Solid TumorsMay 31, 2023
• PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site InfectionsMay 22, 2023
• Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityMay 17, 2023
• Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenMay 11, 2023
• Yotpo Launches eCommerce Retention Marketing Platform and New Pricing to Combat Rising Customer Acquisition Costs and Lower Total Cost of OwnershipMay 10, 2023
• Cleantech startup Tipa acquires Bio4Pack in $8 million dealMay 7, 2023
• Veev Expands Into Single-Family Home Market, Announces New Digital FabMay 2, 2023
• Gamida Cell Announces Pricing of $23 Million Public Offering of SecuritiesApril 19, 2023

• 1
• 2
• 3
• 4
• ...
• 45
• »